Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation

Vitae Pharmaceuticals, Inc (VTAE) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2017 SC 13G/A Cormorant Asset Management, LLC reports a 0% stake in Vitae Pharmaceuticals, Inc.
02/14/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/04/2016 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
10/31/2016 EFFECT Form EFFECT - Notice of Effectiveness
10/25/2016 4 Gregg Richard (Chief Science Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
10/25/2016 4 LEONARD JOHN M. (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
10/25/2016 4 Sable Carole (Chief Medical Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 Hatfield Jeffrey S. (CEO) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 HAYDEN DONALD J JR (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 JUNIUS DANIEL M (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Disposed/sold 20,000 options to buy @ $11.37, valued at $227.4k
10/25/2016 4 Bernstein Karen (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 Fratamico Arthur (Chief Business Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 SANTINI GINO (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Disposed/sold 17,000 options to buy @ $8, valued at $136k
Disposed/sold 10,000 options to buy @ $12.43, valued at $124.3k
Disposed/sold 10,000 options to buy @ $9.62, valued at $96.2k
10/25/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
10/25/2016 4 Applebaum Scott (General Counsel) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
10/25/2016 8-K Quarterly results
10/25/2016 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
10/25/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
10/21/2016 4 Gregg Richard (Chief Science Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/17/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
10/11/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
10/04/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
09/26/2016 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
09/26/2016 SC TO-T Form SC TO-T - Tender offer statement by Third Party
09/21/2016 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
09/16/2016 4 Hatfield Jeffrey S. (CEO) has filed a Form 4 on Vitae Pharmaceuticals, Inc
09/16/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
09/16/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy